Literature DB >> 12588276

Should bivalirudin replace heparin during percutaneous coronary interventions?

Elliott M Antman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588276     DOI: 10.1001/jama.289.7.903

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention.

Authors:  Marit D Moen; Gillian M Keating; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

Authors:  Jeremy A Rassen; Murray A Mittleman; Robert J Glynn; M Alan Brookhart; Sebastian Schneeweiss
Journal:  Eur Heart J       Date:  2009-11-25       Impact factor: 29.983

3.  Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.

Authors:  D P Chew; D L Bhatt; A M Lincoff; K Wolski; E J Topol
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.